216 related articles for article (PubMed ID: 7969490)
1. Gene inhibition using antisense oligodeoxynucleotides.
Wagner RW
Nature; 1994 Nov; 372(6504):333-5. PubMed ID: 7969490
[TBL] [Abstract][Full Text] [Related]
2. Antisense gene inhibition by C-5-substituted deoxyuridine-containing oligodeoxynucleotides.
Gutierrez AJ; Matteucci MD; Grant D; Matsumura S; Wagner RW; Froehler BC
Biochemistry; 1997 Jan; 36(4):743-8. PubMed ID: 9020771
[TBL] [Abstract][Full Text] [Related]
3. Sequence-specific inhibition of gene expression in intact human skin by epicutaneous application of chimeric antisense oligodeoxynucleotides.
Wingens M; Pfundt R; van Vlijmen-Willems IM; van Hooijdonk CA; van Erp PE; Schalkwijk J
Lab Invest; 1999 Nov; 79(11):1415-24. PubMed ID: 10576212
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liver.
Robaczewska M; Guerret S; Remy JS; Chemin I; Offensperger WB; Chevallier M; Behr JP; Podhajska AJ; Blum HE; Trepo C; Cova L
Gene Ther; 2001 Jun; 8(11):874-81. PubMed ID: 11423935
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
Cucco C; Calabretta B
Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles.
Föger F; Noonpakdee W; Loretz B; Joojuntr S; Salvenmoser W; Thaler M; Bernkop-Schnürch A
Int J Pharm; 2006 Aug; 319(1-2):139-46. PubMed ID: 16713146
[TBL] [Abstract][Full Text] [Related]
7. Control of intracellular delivery of oligonucleotides by signal peptides and genetic expression in human cells.
Kubo T; Kanno K; Ohba H; Rumiana B; Fujii M
Nucleic Acids Symp Ser (Oxf); 2004; (48):303-4. PubMed ID: 17150599
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression.
Hung WC; Huang JS; Chuang LY
Biochem Biophys Res Commun; 1996 Mar; 220(3):719-23. PubMed ID: 8607831
[TBL] [Abstract][Full Text] [Related]
9. Effective intracellular delivery of oligonucleotides in order to make sense of antisense.
Shi F; Hoekstra D
J Control Release; 2004 Jun; 97(2):189-209. PubMed ID: 15196747
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic potential of antisense oligonucleotides.
Sharma HW; Narayanan R
Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
[TBL] [Abstract][Full Text] [Related]
11. [The effect of antisense H-ras on growth and metastasis of a high metastatic tumor model of human hepatoma in nude mice LCI-D20].
Liao Y; Tang Z; Sun F
Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):650-3. PubMed ID: 9275544
[TBL] [Abstract][Full Text] [Related]
12. In vivo inhibition of hepatitis B virus gene expression by antisense phosphorothioate oligonucleotides.
Moriya K; Matsukura M; Kurokawa K; Koike K
Biochem Biophys Res Commun; 1996 Jan; 218(1):217-23. PubMed ID: 8573134
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of TF gene expression by antisense oligonucleotides in different cancer cell lines.
Förster Y; Schwenzer B
J Exp Ther Oncol; 2004 Dec; 4(4):281-9. PubMed ID: 15844658
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of N-methyl-D-aspartate glutamate receptor subunit expression by antisense oligonucleotides reveals their role in striatal motor regulation.
Standaert DG; Testa CM; Rudolf GD; Hollingsworth ZR
J Pharmacol Exp Ther; 1996 Jan; 276(1):342-52. PubMed ID: 8558453
[TBL] [Abstract][Full Text] [Related]
15. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
Normand N; Valamanesh F; Savoldelli M; Mascarelli F; BenEzra D; Courtois Y; Behar-Cohen F
Mol Vis; 2005 Mar; 11():184-91. PubMed ID: 15761390
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation.
Cioffi CL; Garay M; Johnston JF; McGraw K; Boggs RT; Hreniuk D; Monia BP
Mol Pharmacol; 1997 Mar; 51(3):383-9. PubMed ID: 9058592
[TBL] [Abstract][Full Text] [Related]
17. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
[TBL] [Abstract][Full Text] [Related]
18. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
[TBL] [Abstract][Full Text] [Related]
19. [Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes].
Sommer W; Heilig M
Lakartidningen; 1999 Jan; 96(4):348-54. PubMed ID: 10024826
[TBL] [Abstract][Full Text] [Related]
20. Alpha 6 and gamma 2 subunit antisense oligodeoxynucleotides alter gamma-aminobutyric acid receptor pharmacology in cerebellar granule neurons.
Zhu WJ; Wang JF; Vicini S; Grayson DR
Mol Pharmacol; 1996 Jul; 50(1):23-33. PubMed ID: 8700115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
